Filing Overview
The provided Form 8-K is for Brilliant Acquisition Corporation, not T3 Defense Inc. The report covers events occurring July 20–21, 2023. Brilliant is a British Virgin Islands special purpose acquisition company pursuing a proposed merger with Nukkleus, Inc., under which Nukkleus would become a wholly owned subsidiary of Brilliant.
Key Financial and Capital Structure Information
- Brilliant issued Nukkleus an unsecured, non-interest-bearing promissory note for $32,300 dated July 20, 2023.
- The note matures upon closing of the initial business combination. If no business combination occurs, repayment is limited to amounts remaining outside the trust account, if any.
- Note proceeds were deposited into the trust account in connection with extending the business-combination deadline.
- Following redemptions and the contribution described in the filing, the trust account contained approximately $4.5 million, or approximately $11.17 per public share.
- After the special meeting, Brilliant had 1,814,696 ordinary shares outstanding, including 1,411,000 shares held by initial shareholders and not subject to redemption.
- The filing does not provide revenue, operating profit, net income, cash-flow, margin, or broader debt metrics for the reporting period.
Material Changes and Shareholder Actions
- Shareholders approved extending the business-combination deadline from July 23, 2023 to no later than December 23, 2023.
- The extension may be continued monthly without further shareholder approval through deposits of $0.08 per outstanding public ordinary share.
- Shareholders approved the related amended and restated articles of association, which were filed with the British Virgin Islands General Registry on July 21, 2023.
- Public shareholders elected to redeem an aggregate of 1,779 shares.
- Both extension-related proposals received 1,346,399 votes for, 4,349 against, and zero abstentions.
- Brilliant announced a further one-month extension of the completion period to August 23, 2023.
Outlook, Risks, and Unusual Items
The principal outlook item is completion of the proposed Nukkleus business combination. Completion remains subject to applicable closing conditions, including shareholder approvals, maintaining the required minimum trust-account balance after redemptions, and obtaining governmental and regulatory approvals.
- The transaction may not close by the applicable deadline or may not close at all.
- Additional extensions may require further trust-account contributions and may not be available.
- The transaction could be affected by redemption levels, regulatory approvals, legal proceedings, Nasdaq listing requirements, market volatility, and changes in the combined capital structure.
- The filing cautions that the proposed transaction could disrupt Nukkleus’s business relationships, operations, employee retention, and implementation of business plans.
- The promissory note is an unusual financing obligation because it is unsecured, non-interest-bearing, and payable from funds outside the trust account if the business combination is not completed.
Investor Verification Checklist
- Verify the registrant identity, since the supplied metadata identifies T3 Defense Inc. while the filing names Brilliant Acquisition Corporation.
- Review the full promissory note and confirm its repayment terms and relationship to the trust account.
- Confirm the remaining trust-account balance, public share count, redemption amount, and applicable per-share distribution.
- Track whether the Nukkleus transaction satisfies all closing conditions and whether further extensions are required.
- Review the forthcoming or filed Form S-4, proxy statement/prospectus, and related risk factors before making an investment or voting decision.